Yüklüyor......
Oncolytic efficacy of thymidine kinase-deleted vaccinia virus strain Guang9
Oncolytic virotherapy is being developed as a promising platform for cancer therapy due to its ability to lyse cancer cells in a tumor-specific manner. Vaccinia virus has been used as a live vaccine in the smallpox eradication program and now is being potential in cancer therapy with a great safety...
Kaydedildi:
| Yayımlandı: | Oncotarget |
|---|---|
| Asıl Yazarlar: | , , , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Impact Journals LLC
2017
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5522336/ https://ncbi.nlm.nih.gov/pubmed/28465492 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.17125 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|